#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11698	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1991	574.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1425	1425	C	637	C	619	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11698	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1991	574.8	0	HET	.	.	.	C451T	.	451	451	C	692	692	C	675	C,T	468,181	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11698	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1991	574.8	0	HET	.	.	.	C207T	.	207	207	C	448	448	C	684	C,T	545,111	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22158	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3599	609.7	0	.	n	.	0	T695C	SNP	695	695	T	1026	1026	C	664	C,A	649,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22158	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3599	609.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2302	2302	C	647	C,T	626,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22158	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3599	609.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2376	2376	A	633	A	617	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22158	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3599	609.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2928	2928	C	654	C,A,T	634,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1378	folP	855	855	100.0	folP.l15.c30.ctg.1	1659	82.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1148	1150	AGC	131;132;133	A;G;C	130;129;130	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3602	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	102.4	1	SNP	p	S91F	1	.	.	271	273	TTC	602	604	TTC	123;121;122	T;T;C	116;114;116	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3602	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	102.4	1	SNP	p	D95G	1	.	.	283	285	GGC	614	616	GGC	128;125;127	G;G;C	121;120;122	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3602	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3490	102.4	1	SNP	p	G95N	0	.	.	283	285	GGC	614	616	GGC	128;125;127	G;G;C	121;120;122	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1242	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1392	87.8	1	SNP	p	G45D	0	.	.	133	135	GGC	414	416	GGC	157;158;154	G,T,C;G;C	152,1,1;154;151	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	586	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1001	57.6	0	.	n	.	0	A197.	DEL	197	197	A	606	606	A	126	A	124	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	137.7	1	SNP	p	D86N	0	.	.	256	258	GAC	556	558	GAC	179;179;180	G;A;C	174;170;176	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	137.7	1	SNP	p	R87W	0	.	.	259	261	CGT	559	561	CGT	177;180;180	C;G;T	174;178;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	137.7	1	SNP	p	S87R	1	.	.	259	261	CGT	559	561	CGT	177;180;180	C;G;T	174;178;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	137.7	1	SNP	p	R87I	0	.	.	259	261	CGT	559	561	CGT	177;180;180	C;G;T	174;178;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4158	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2978	137.7	1	SNP	p	S88P	0	.	.	262	264	TCC	562	564	TCC	182;182;178	T;C;C	178;177;176	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2740	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2650	102.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1564	1566	GGC	141;134;135	G;G,A;C	138;129,1;130	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1281	1283	GCC	163;164;164	G;C;C	160;160;161	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1284	1286	ATG	162;162;162	A;T;G	160;159;156	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1296	1298	ACC	160;161;161	A;C;C,A	154;159;154,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1296	1298	ACC	160;161;161	A;C;C,A	154;159;154,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1797	1799	ACC	151;153;154	A,T,C;C;C	140,1,1;149;147	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1851	1853	GCG	124;126;124	G;C;G	121;122;121	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1851	1853	GCG	124;126;124	G;C;G	121;122;121	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1974	1976	GGT	122;121;120	G;G;T	119;116;116	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1983	1985	AGC	111;111;109	A;G;C	107;108;107	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2878	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2447	116.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2001	2003	CCG	91;92;92	C,G;C,G;G,C	82,5;81,3;80,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4534	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3225	139.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1715	1717	CCG	142;142;143	C,G;C;G,C	131,1;139;132,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1846	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1868	97.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	565	565	C	128	C	121	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1495	167.8	0	.	p	.	0	E209K	NONSYN	625	627	GAA	874	876	AAA	209;209;207	A;A;A	202;204;203	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1495	167.8	0	.	p	.	0	A212E	NONSYN	634	636	GCA	883	885	GAA	201;204;203	G;A;A	196;197;198	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1495	167.8	1	SNP	p	G120K	1	.	.	358	360	AAG	607	609	AAG	205;207;206	A;A;G,A	195;199;184,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1495	167.8	1	SNP	p	N121D	0	.	.	361	363	AAC	610	612	AAC	203;204;205	A,G;A;C,A	194,1;192;195,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2550	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1495	167.8	1	SNP	p	A121N	1	.	.	361	363	AAC	610	612	AAC	203;204;205	A,G;A;C,A	194,1;192;195,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9126	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4924	183.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1020	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1143	88.5	1	SNP	p	V57M	1	.	.	169	171	ATG	528	530	ATG	198;200;199	A;T;G	190;193;189	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
